A vitreous enamel coating for an electrosurgical metal cutting blade, in which incident light striking the vitreous enamel coating is diffusely reflected or absorbed, and the vitreous enamel coating exhibits a 60 gloss value less than 100 gloss units as measured according to ASTM D523-14, Standard Test Method for Specular Gloss. The coating reduces glare from light sources such as a nearby plasma-mediated discharge, operating theater lights or lights provided on an electrosurgery apparatus. The coating may also lessen interference with markers, sensors or other instruments designed to measure light emitted by or passing through nearby tissue such as by transillumination.

A method for fabricating a medical device includes steps as follows: A degradable powder including at least one metal element is firstly provided on a target surface. A focused energy light bean is applied to sinter/cure the biodegradable powder within an oxygen-containing atmosphere; wherein the oxygen concentration of the oxygen-containing atmosphere is adjusted to provide a first oxygen concentration and a second concentration when the focused energy light is driven to a first location and second location of the target surface respectively. The aforementioned processes are then repeatedly carried out to form a three-dimensional (3D) structure of the medical device.

A vitreous enamel coating for an electrosurgical metal cutting blade, the coating having a coefficient of thermal expansion substantially near the coefficient of thermal expansion of the metal cutting blade. Selection of materials having similar coefficients of thermal expansion results in an electrosurgical cutting blade with an improved insulating layer, substantially improved durability, or both.

In some examples, a medical device system a thin film including at least one electrically conductive track extending between at least one electrode and at least one electrical contact, a first and second polymer layer; wherein, at a portion of the thin film between the at least one electrode and the at least one electrical contact, the first polymer layer and second polymer layer surround the at least one electrically conductive track; and at least one discrete ceramic member located between the first and second polymer layers at a portion of the thin film between the at least one electrode and the at least one electrical contact, wherein the at least one discrete ceramic member does not surround the at least one conductive track, and wherein the at least one discrete ceramic member is configured to increase adhesion between the first polymer layer and second polymer layer.

An element composed of glass displaying reduced electrostatic charging is provided. The element is suitable as a housing component for electronic elements, an element implantable in the human or animal body including glass tubes for reed switches or transponders and/or implants. The glass includes at least one alkali metal and/or an alkali metal oxide and has a surface. The concentration of at least one alkali metal and/or the alkali metal oxide increases from the surface in a direction of an interior of the element in such a way that a maximum concentration of the alkali metal and/or the alkali metal oxide occurs at a distance of not more than 60 nanometres, measured perpendicularly from the surface.

An intraoral imaging apparatus for tomosynthesis imaging has an x-ray source having a primary collimator that defines boundaries of a radiation field. A transport apparatus translates the x ray source along a path for tomographic imaging. An intraoral x-ray detector defines an imaging area for the radiation field. A positioning apparatus correlates the position of the intraoral detector to the position of a secondary collimator. One or more radio-opaque markers provided on a detector attachment is coupled to the detector, the one or more markers configured to condition acquired x-ray images to relate the spatial position of the intraoral x-ray detector to the x-ray source position, wherein the one or more markers are disposed within the defined imaging area. A control logic processor accepts image data from the detector and determines the relative location of the source with respect to the detector according to detected marker position.

A biocompatible electrical connection includes a substrate; a ferrule having a concentric flange at a first end of the ferrule; a first adhesive; and a second adhesive. The first adhesive adheres a first surface of the concentric flange of the ferrule to a surface of the substrate. The second adhesive fills an annular space between a hole in the substrate and the ferrule. The first adhesive or the second adhesive forms a conductive path on the surface of the substrate between the ferrule and a circuit pattern on the substrate.

An auto-injector device includes a pre-filled syringe including a container and a stainless steel needle adhered to the container with at least one of a urethane acrylate adhesive or a urethane methacrylate adhesive. The container is filled with at least 1 mL of a pharmaceutical composition comprising epinephrine, a buffer, and water, where the pharmaceutical composition has a pH ranging between 3 and 4. The auto-injector device also includes a firing mechanism that expels about 0.3 mL of the pharmaceutical composition from the container in less than 0.5 seconds during a single injection.

Disclosed herein is a method of using a biomaterial for treating a condition. The biomaterial can comprise a plurality of geometric elements. Implantation of a biomaterial disclosed herein into a subject can treat, for example, cancer.

The present invention relates to a device for guided bone regeneration, intended for the reconstruction of a buccal bone defect, composed of zirconium dioxide and having a shape which covers said buccal bone defect. The present invention also relates to a method for producing a device of the invention, comprising a step of constructing the device of the invention according to a three-dimensional representation obtained by means of a technique of maxillo-dental imaging of the bone defect.